PDF Archive search engine
Last database update: 25 October at 15:41 - Around 76000 files indexed.
However with the recent developments in the fields of genomics, proteomics and metabolomics, biological molecules have become an important tool for the treatment of diseases or help understanding biological processes.
From Genomics to the Clinic Ana Vivancos (VHIO) TBC Janne Lehtio (KI) Cancer Proteomics - complementing genotype with molecular phenotype Discussion Stefan Pfister (DKFZ) Molecular brain tumor classification - from bench to bedside René Bernards (NKI) Science-driven personalized medicine beyond simple genotyping Olli Kallioniemi (KI) Systems medicine to guide cancer treatment decisions and drug development Discussion Lukas Amler - Roche-Genentech Exploring and understanding patient heterogeneity for treatment with checkpoint inhibitors Cocktail reception following the scientific program 08:30 AM - 4:15 PM 08:30 08:40 8:50 - 10:15 AM 08:50 09:10 09:30 09:45 DAY 2 - WEDNESDAY, FEB 1st SCIENTIFIC TALKS - all talks will be held in the Lecture Hall Short talk - CCC Radiomics of primary staging diffusion-weighted MRI to predict neoadjuvant treatment response in Short talk - Joost van Griethuysen (NKI) rectal cancer SESSION 2:
He is generally recognized as one of the founding fathers of proteomics, and has contributed to over 300 publications, including eight books.
After counting them, their genomics and proteomics were analyzed.
Authors:Chen-Hsien Su,Wen-Shin Chang,Pei-Shin Hu,Chieh-Lun Hsiao,Hong-Xue Ji,Cheng-Hsi Liao,Te-Cheng Yueh,Chin-Liang Chuang,Chia-Wen Tsai,Chin-Mu Hsu, Hsien-Yuan Lane,Da-Tian Bau Cancer Genomics Proteomics 2015 Nov-Dec;12(6):359-67(IF:
The various ‘omics’ such as transcriptomics, epigenetics, miRNA, proteomics, phosphoproteomics and metabolomics introduce further variants to the molecule target for external imaging .